The Food and Drug Administration is expanding approval of leucovorin to treat an ultra-rare genetic condition.

Funds for Medicaid spent on autism centers has spiked in North Carolina, the state auditor told a legislative committee on ...

The Food and Drug Administration has sharply narrowed the approved uses of leucovorin, limiting the drug to a rare genetic disorder, a significant pullback after President Donald Trump and Health and ...

It's a major step back from statements made at a White House news conference in September, when President Donald Trump and ...

The FDA is approving a generic drug for a very rare genetic disorder, but not for autism. On Tuesday, the U.S. agency said ...

Drug's approval expanded, but only to patients with genetic cerebral folate transport defi ...

In September, Trump and the FDA commissioner announced the drug was under review to benefit patients with autism. The FDA didn't find evidence of that.

WASHINGTON (AP) — The Food and Drug Administration on Tuesday approved a generic medication for a rare brain disorder, while walking back suggestions by President Donald Trump and other administration ...

The agency said it approved leucovorin for children and adults with a genetic condition that limits delivery of folate, a form of vitamin B, to the brain. FDA officials estimate the ultrarare ...

The FDA’s decision represents a major scaling back of the vision presented by Commissioner Marty Makary and Health Secretary Robert F. Kennedy Jr. in September 2025. At that time, officials suggested ...

The Food and Drug Administration on Tuesday approved a generic medication for a rare brain disorder, while walking back ...

What is leucovorin? FDA expands drug’s approved use but walks back autism claims - Unresolved questions about the drug haven’t stopped U.S. doctors from prescribing it ...